
Veru Inc (NASDAQ:VERU) shares are trading higher in Monday's after-hours session on continued momentum from the regular session.
The stock closed up more than 180% after the company announced its novel COVID-19 drug candidate reduced deaths by 55% in hospitalized patients in an interim analysis of the Phase 3 study.